The Immunohematology and Immune Dysregulation Program provides comprehensive immune system and genetic evaluations that lead to targeted and individualized therapies. Our team works closely with other specialties, including rheumatology, gastroenterology, hematology, and oncology to complement care and assist in genetic diagnosis and treatment options.
For more information, click here.
The curative therapies program offers sickle cell disease patients comprehensive evaluation, coordinated care and various treatment options that include bone marrow transplant (BMT) and gene therapy.
For more information, click here.
More info coming soon!
The Sickle Cell Disease Pain Treatment Program for children and teens has the goal of treating patients by reducing their pain as much as possible, helping them function at their best and avoiding side effects.
For more information, click here.
The GSSCI is an independent research initiative which includes some members of the Aflac Cancer and Blood Disorders Center.
For more information, click here.
Meet the Team
Shannon Meeks, MD, MBA
Section Chief of Hematology